Santo Domingo, May 16 (Prensa Latina) The Dominican Republic will administer two Cuban biotechnological products in the treatment of oncological diseases, including CIMAvax-EGF, the first therapeutic vaccine against lung cancer with a proven impact on the health of the population, it was announced on Monday.